| Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer J Kos, TT Lah Oncology reports 5 (6), 1349-1410, 1998 | 375 | 1998 |
| Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track–letter A Torsvik, GV Røsland, A Svendsen, A Molven, H Immervoll, ... Cancer research 70 (15), 6393-6396, 2010 | 357 | 2010 |
| The role of reactive oxygen species in microcystin-LR-induced DNA damage B Žegura, TT Lah, M Filipič Toxicology 200 (1), 59-68, 2004 | 246 | 2004 |
| Proteases in brain tumour progression N Levičar, RK Nutall, TT Lah Acta neurochirurgica 145, 825-838, 2003 | 228 | 2003 |
| Cysteine proteinases in cancer progression and their clinical relevance for prognosis. TT Lah, J Kos Biological chemistry 379 (2), 125-130, 1998 | 168 | 1998 |
| Human mesenchymal stem cells and their use in cell‐based therapies H Motaln, C Schichor, TT Lah Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 167 | 2010 |
| Degradation of laminin by human tumor cathepsin B TT Lah, MR Buck, KV Honn, JD Crissman, NC Rao, LA Liotta, BF Sloane Clinical & experimental metastasis 7, 461-468, 1989 | 163 | 1989 |
| Stefins and lysosomal cathepsins B, L and D in human breast carcinoma TT Lah, M Kokalj‐Kunovar, B Štrukelj, J Pungerčar, D Barlič‐Maganja, ... International journal of cancer 50 (1), 36-44, 1992 | 152 | 1992 |
| Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators TT Lah, M Cercek, A Blejec, J Kos, E Gorodetsky, R Somers, I Daskal Clinical Cancer Research 6 (2), 578-584, 2000 | 144 | 2000 |
| Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer T Castiglioni, MJ Merino, B Elsner, TT Lah, BF Sloane, MR Emmert-Buck Human pathology 25 (9), 857-862, 1994 | 125 | 1994 |
| Prognostic impact of CD68 and kallikrein 6 in human glioma T Strojnik, R Kavalar, I Zajc, EP Diamandis, K Oikonomopoulou, TT Lah Anticancer research 29 (8), 3269-3279, 2009 | 101 | 2009 |
| CD133+ and Nestin+ Glioma Stem-Like Cells Reside Around CD31+ Arterioles in Niches that Express SDF-1α, CXCR4, Osteopontin and Cathepsin K VVV Hira, KJ Ploegmakers, F Grevers, U Verbovšek, C Silvestre-Roig, ... Journal of Histochemistry & Cytochemistry 63 (7), 481-493, 2015 | 96 | 2015 |
| Cell adhesion on polycaprolactone modified by plasma treatment N Recek, M Resnik, H Motaln, T Lah-Turnšek, R Augustine, N Kalarikkal, ... International Journal of Polymer Science 2016, 2016 | 92 | 2016 |
| Acid sulphydryl protease from calf lymph nodes T Turnšek, I Kregar, D Lebez Biochimica et Biophysica Acta (BBA)-Enzymology 403 (2), 514-520, 1975 | 85 | 1975 |
| Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines B Breznik, H Motaln, M Vittori, A Rotter, TL Turnšek Oncotarget 8 (15), 25482, 2017 | 79 | 2017 |
| Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells N Podergajs, H Motaln, U Rajčević, U Verbovšek, M Koršič, N Obad, ... Oncotarget 7 (1), 593, 2016 | 78 | 2016 |
| Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro C Schichor, V Albrecht, B Korte, A Buchner, R Riesenberg, J Mysliwietz, ... Experimental neurology 234 (1), 208-219, 2012 | 70 | 2012 |
| Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance H Motaln, A Koren, K Gruden, Ž Ramšak, C Schichor, TT Lah Oncotarget 6 (38), 40998, 2015 | 69 | 2015 |
| The regulation of cysteine cathepsins and cystatins in human gliomas B Gole, PC Huszthy, M Popović, J Jeruc, YS Ardebili, R Bjerkvig, TT Lah International journal of cancer 131 (8), 1779-1789, 2012 | 55 | 2012 |
| CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids S Ardebili, I Zajc, B Gole, B Campos, C Herold-Mende, S Drmota, T Lah Radiology and oncology 45 (2), 102-115, 2011 | 52 | 2011 |
Janko KosProfessor of Biochemistry, Faculty of Pharmacy, University of LjubljanaVerifierad e-postadress på ffa.uni-lj.si
